Oxea wraps up cross-border cov-lite deal, tranches priced at tight end of guidance
German chemicals firm Oxea has signed a new €1.1bn-equivalent cov-lite debt package. The senior credit facilities will refinance existing debt, as well as pay shareholders a dividend of €600m.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
